VGXI
Mr. Park serves as CEO for both GeneOne Life Science, Inc. (KOSPI: 011000) and VGXI, Inc., a GeneOne company. Over the past 15 years, he has overseen the explosive growth of VGXI into the global leader in the manufacture of cGMP DNA plasmids central to gene-based biomedicines, including cell and gene therapies, and DNA vaccines. Mr. Park obtained a B.A. in Economics from Dickinson College, a J.D. from University of Pennsylvania Law School, and an M.S. in Finance and Applied Economics from Massachusetts Institute of Technology Sloan School of Management.
This person is not in any offices
VGXI
VGXI is a contract manufacturing organization that produces DNA plasmids under GMP for human clinical trials.